Use of Real‐World Data and Real‐World Evidence in Rare Disease Drug Development: A Statistical Perspective

Ähnliche Einträge

• Challenges and Possible Strategies to Address Them in Rare Disease Drug Development: A Statistical Perspective
  von: Jie Chen, et al.
  Veröffentlicht: (2025)
• Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective
  von: Chen, Jie, et al.
  Veröffentlicht: (2024)
• Balancing Reassurance and Vigilance: Real‐World Evidence in Post‐Marketing Drug Safety
  von: Yow‐Ming C. Wang, et al.
  Veröffentlicht: (2026)
• Value of Pharmacogenetic Testing Assessed with Real‐World Drug Utilization and Genotype Data
  von: Kaisa Litonius, et al.
  Veröffentlicht: (2024)
• US Food and Drug Administration's Advancing Real‐World Evidence Program: Initial Experience
  von: Kimberly A. Smith, et al.
  Veröffentlicht: (2025)